By indication / PSMA-directed radioligand therapy

PSMA-directed radioligand therapy

0 imaging agents and 26 therapeutic agents reported for this indication. Stage reflects how far each has been taken, not what is available in any given country.

Imaging

Nothing indexed under this heading yet.

Therapy

AgentIsotopeStageSyntheses
[177Lu]Lu-PSMA-617
paired with [68Ga]Ga-PSMA-11
Lu-177approved96
[177Lu]Lu-PSMA-I&T
paired with [68Ga]Ga-PSMA-I&T
Lu-177Investigational / clinical (academic use)39
[225Ac]Ac-PSMA-617
paired with [111In]In-PSMA-617
Ac-225investigational21
[177Lu]Lu-LuPSMA-617Lu-177approved8
[225Ac]Ac-PSMA-I&T
paired with [68Ga]Ga-PSMA-I&T
Ac-225phase I clinical trial (planned/dose escalation)7
[177Lu]Lu-PSMA-ALB-56Lu-177—4
[177Lu]Lu-P17-087Lu-177investigational3
[177Lu]Lu-P17-088Lu-177clinical investigation3
[177Lu]Lu-J591Lu-177investigational3
[225Ac]Ac-J591Ac-225first-in-human phase I dose-escalation trial2
[177Lu]Lu-rhPSMA-7
paired with [18F]rhPSMA-7
Lu-177—2
[211At]At-PSMA-5At-211first-in-human / preclinical (preparation for first-in-human clinical trial)2
[177Lu]Lu-Ibu-DAB-PSMALu-177preclinical study2
[212Pb]Pb-AB001Pb-212—2
[161Tb]Tb-PSMA-617
paired with [111In]In-PSMA-617
Tb-161investigational1
[213Bi]Bi-PSMA-617
paired with [111In]In-PSMA-617
Bi-213—1
[177Lu]Lu-SibuDABLu-177—1
[177Lu]Lu-EB-PSMA-617Lu-177pilot study1
[177Lu]Lu-PSMA-1-DOTA
paired with [68Ga]PSMA-1-DOTA
Lu-177compassionate use1
[177Lu]Lu-HTK03170Lu-177Reported once1
[68Ga]HTK03149
paired with [177Lu]Lu-HTK03149
Ga-68Reported once1
[177Lu]Lu-HTK03149
paired with [68Ga]HTK03149
Lu-177Reported once1
[177Lu]Lu-rhPSMA-10Lu-177phase I
[225Ac]Ac-SibuDABAc-225investigational
[177Lu]Lu-PSMA-617-treatedLu-177investigational
[211At]At-astatinatedAt-211—

Have a question?Reagents, modules, introductions to manufacturers or to specialists in your region — tell us what you need.

Get in touch